GlassScriptPhysician profile
Carrie Hostetler
NPI 1528588639
$2,778.77
in general payments reported to CMS, 2019-2025
16 companies · $2,175 in 2025
The $2,175 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $108 · 2024: $495 · 2025: $2,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,778.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $750.48 | 2024-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $397.71 | 2024-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $386.28 | 2025 | |
| Pfizer INC. | $295.76 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $260.34 | 2024-2025 | Cuvitru |
| Regeneron Healthcare Solutions, INC. | $201.67 | 2024-2025 | Dupixent |
| Biocryst US Sales Co., LLC | $87.77 | 2024-2025 | Orladeyo |
| Amgen INC. | $73.45 | 2024-2025 | Tezspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.44 | 2023 | Relistor |
| Novartis Pharmaceuticals Corporation | $56.06 | 2025 | |
| Lilly USA, LLC | $53.27 | 2025 | Ebglyss |
| Averitas Pharma INC. | $46.00 | 2023 | Qutenza |
| Genentech USA, INC. | $41.02 | 2025 | Xolair |
| Ionis Pharmaceuticals, INC. | $29.12 | 2025 | Dawnzera |
| Csl Behring | $19.02 | 2025 | Haegarda |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $18.38 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Hostetler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.